RK

Reeta Kumari

Active Director Director DIN 10353980
DIN 10353980 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Reeta Kumari

Data last updated:

Reeta Kumari is a Director at Synaxia Lifesciences Private Limited (since 2023). The company operates in Pharma. Synaxia Lifesciences Private Limited reported revenue of ₹7.3 Lakh (FY 2025).

DIN 10353980
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2023
Oldest Company Age 3 yrs
Largest company Synaxia Lifesciences Private Limited · ₹7.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synaxia Lifesciences Private Limited U46497DL2023PTC421274
Director13 Oct 20232023₹7.3 Lakh (FY 2025)Active

Board colleagues of Reeta Kumari

Directorship timeline

Open interactive timeline →
Synaxia Lifesciences Private Limited
Premium access

Shareholding and investment profile for Reeta Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reeta Kumari

Reeta Kumari currently holds 1 directorship: Synaxia Lifesciences Private Limited (Director, since 13 Oct 2023, revenue ₹7.3 Lakh (FY 2025)).

Reeta Kumari was first appointed on 13 Oct 2023 as Director at Synaxia Lifesciences Private Limited.

The current boards of Reeta Kumari's companies include Bhaskar Tripathi (Synaxia Lifesciences Private Limited), Mandaabi Mishra (Synaxia Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available